Pamela Bunner

Intermediate-Dose versus Low-Dose Cyclophosphamide and Granulocyte Colony-Stimulating Factor for Peripheral Blood Stem Cell Mobilization in Patients with Multiple Myeloma Treated with Novel Induction Therapies

Mehdi Hamadani, Samith T. Kochuparambil, Salman Osman et al. · Biology of Blood and Marrow Transplantation · 2012 · 72 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Sibling Donor and Recipient Immune Modulation With Atorvastatin for the Prophylaxis of Acute Graft-Versus-Host Disease

Mehdi Hamadani, Laura F. Gibson, Scot C. Remick et al. · Journal of Clinical Oncology · 2013 · 45 citations · Full text

Life Sciences, Hematology, Immunology +16

Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan‐based reduced toxicity conditioning

Mehdi Hamadani, Michael Craig, Gary Phillips et al. · Hematological Oncology · 2011 · 14 citations

Medicine, Immunology, Immunotherapy +12

Recipient Immune Modulation with Atorvastatin for Acute Graft-versus-Host Disease Prophylaxis after Allogeneic Transplantation

Abraham S. Kanate, Parameswaran Hari, Marcelo C. Pasquini et al. · Biology of Blood and Marrow Transplantation · 2017 · 11 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Higher infused CD34+ cell dose and overall survival in patients undergoing in vivo T-cell depleted, but not t-cell repleted, allogeneic peripheral blood hematopoietic cell transplantation

Abraham S. Kanate, Michael Craig, Aaron Cumpston et al. · Hematology/Oncology and Stem Cell Therapy · 2011 · 10 citations · Full text

Medicine, Hematology, Immunology +17